231 related articles for article (PubMed ID: 25204258)
21. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of drug-drug interaction in atrial fibrillation patients based on a large claims data.
Momo K; Kobayashi H; Sugiura Y; Yasu T; Koinuma M; Kuroda SI
PLoS One; 2019; 14(12):e0225297. PubMed ID: 31815956
[TBL] [Abstract][Full Text] [Related]
23. Adverse Drug Reactions in Patients Receiving Systemic Antifungal Therapy at a High-Complexity Hospital.
de Souza MC; Santos AG; Reis AM
J Clin Pharmacol; 2016 Dec; 56(12):1507-1515. PubMed ID: 27198583
[TBL] [Abstract][Full Text] [Related]
24. Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico.
Morales-Ríos O; Jasso-Gutiérrez L; Reyes-López A; Garduño-Espinosa J; Muñoz-Hernández O
PLoS One; 2018; 13(1):e0190882. PubMed ID: 29304072
[TBL] [Abstract][Full Text] [Related]
25. Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.
Chatsisvili A; Sapounidis I; Pavlidou G; Zoumpouridou E; Karakousis VA; Spanakis M; Teperikidis L; Niopas I
Pharm World Sci; 2010 Apr; 32(2):187-93. PubMed ID: 20077137
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital.
Wang H; Shi H; Wang N; Wang Y; Zhang L; Zhao Y; Xie J
BMC Pharmacol Toxicol; 2022 Jun; 23(1):39. PubMed ID: 35701808
[TBL] [Abstract][Full Text] [Related]
27. Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: prevalence, clinical importance and associated factors.
Lubinga SJ; Uwiduhaye E
Afr Health Sci; 2011 Sep; 11(3):499-507. PubMed ID: 22275946
[TBL] [Abstract][Full Text] [Related]
28. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
29. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
[TBL] [Abstract][Full Text] [Related]
30. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
32. Drug-drug interactions in patients receiving hematopoietic stem cell transplantation.
Pejčić A; Janković SM; Opančina V; Babić G; Milosavljević M
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):49-59. PubMed ID: 30479183
[TBL] [Abstract][Full Text] [Related]
33. Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions.
Guidoni CM; Camargo HP; Obreli-Neto PR; Girotto E; Pereira LR
Int J Clin Pharm; 2016 Oct; 38(5):1048-51. PubMed ID: 27365092
[TBL] [Abstract][Full Text] [Related]
34. Clinically relevant drug-drug interactions among elderly people with dementia.
Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M
Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921
[TBL] [Abstract][Full Text] [Related]
35. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis.
Zheng WY; Richardson LC; Li L; Day RO; Westbrook JI; Baysari MT
Eur J Clin Pharmacol; 2018 Jan; 74(1):15-27. PubMed ID: 29058038
[TBL] [Abstract][Full Text] [Related]
36. Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay.
Sanchez L; Bacle A; Lamy T; Le Corre P
Cancer Chemother Pharmacol; 2019 May; 83(5):827-835. PubMed ID: 30758649
[TBL] [Abstract][Full Text] [Related]
37. Drug-drug interactions in cancer chemotherapy: an observational study in a tertiary health care centre.
Singh H; Singh B
Drug Metab Pers Ther; 2017 Dec; 32(4):219-223. PubMed ID: 29135452
[TBL] [Abstract][Full Text] [Related]
38. Drug-drug interactions in Neonatal Intensive Care Units: how to overcome a challenge.
Rosen K; Wiesen MH; Oberthür A; Michels G; Roth B; Fietz C; Müller C
Minerva Pediatr (Torino); 2021 Apr; 73(2):188-197. PubMed ID: 31621271
[TBL] [Abstract][Full Text] [Related]
39. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
40. Concordance of severity ratings provided in four drug interaction compendia.
Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
